New Thoracic Pain in a Cancer Survivor Scheduled for Epidural Steroid Injection
A 64-year-old woman with stage II breast cancer treated with lumpectomy, radiation, and tamoxifen in 2018, now in remission, presents with six weeks of mid-thoracic pain. It began without trauma, is worse at night and when lying flat, and is not relieved by rest. She describes a band-like tightness at T6 that occasionally feels sharp. She has no fever, no weakness, and no bowel or bladder change. Her primary physician diagnosed degenerative disc disease on plain films and scheduled her for a thoracic interlaminar epidural steroid injection next week. Laboratory studies drawn at a routine visit show alkaline phosphatase 168 U/L (reference <120) with normal transaminases. She takes only tamoxifen and naproxen.
1. What features of this presentation should make you pause before proceeding with the scheduled injection, and why?
Read the worked answer
This is a red-flag constellation, not mechanical thoracic pain:
- New pain in a patient with a prior malignancy - breast cancer metastasizes to bone, and the thoracic spine is a common site.
- Night pain and rest pain that do not settle - the classic pattern of bone pain, in contrast to mechanical pain that eases with unloading.
- Band-like thoracic quality - suggests a segmental, possibly epidural or nerve-root level process rather than facet or discogenic pain.
- Isolated alkaline phosphatase elevation with normal transaminases - points to a bone source of the enzyme, not liver.
- Plain-film "degenerative changes" - an expected incidental finding at 64 and not an explanation for six weeks of progressive rest pain. Degenerative change on radiographs has no discriminatory value here.
Proceeding would do two harms: it treats a presumed benign generator that may not exist, and it inserts a delay between a potentially treatable metastasis and its diagnosis. Steroid would also transiently blur the clinical picture. The correct move is to hold the injection and work up the diagnosis, not to cancel the patient.
2. What is your diagnostic sequence, and what would you do if MRI is unremarkable but suspicion remains high?
Read the worked answer
Sequence
- MRI of the thoracic spine with and without contrast - the study of choice for marrow replacement, epidural extension, and cord compression. Contrast adds sensitivity for leptomeningeal and epidural disease.
- If MRI is contraindicated (pacemaker, retained hardware), CT myelogram.
- Laboratory confirmation and staging input: CBC with differential, comprehensive metabolic panel including calcium, and - if myeloma is a consideration - serum protein electrophoresis with free light chains, since myeloma typically produces lytic lesions with a normal alkaline phosphatase. ESR and CRP help if infection or inflammation is on the list.
- Communicate directly with oncology before any procedure; the oncology team owns staging and systemic therapy decisions.
If MRI is negative but suspicion persists
- Move to FDG-PET/CT or bone scintigraphy, which detect metabolically active skeletal disease before marrow replacement is visible.
- Repeat targeted imaging in 4–6 weeks rather than declaring the pain benign.
- Consider non-malignant mimics: osteoporotic compression fracture (tamoxifen is bone-protective, but prior radiation and aromatase-inhibitor exposure in other patients matter), herpes zoster sine herpete, and vertebral osteomyelitis.
A negative scan lowers probability; it does not close the question when the clinical pattern is this typical.
3. If imaging ultimately shows a pathologic fracture from metastatic disease, what role, if any, does the interventional pain physician have?
Read the worked answer
A substantial one, but as part of an oncology-directed plan rather than as a standalone proceduralist.
- Vertebral augmentation (kyphoplasty or vertebroplasty) for a painful pathologic compression fracture without cord compression or posterior element involvement; it can produce meaningful analgesia and reduce opioid requirements. Coordinate timing with radiation and systemic therapy.
- Regional analgesia for chest wall and rib pain - erector spinae plane, paravertebral, or intercostal blocks - as a bridge during radiation or while systemic therapy takes effect.
- Intrathecal drug delivery in selected refractory cases, though this is a late option and requires stability and prognosis sufficient to justify implantation.
- Coordination with radiation oncology: external beam radiation is first-line for painful bone metastases and should not be delayed by a block.
The boundary to respect is that pain interventions relieve suffering; they do not alter tumor biology, and they must not displace staging, systemic therapy, or cord-compression surveillance. The interventionalist's value here is timing and integration, not the needle itself.